Advisors Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $170K | Sell |
3,085
-751
| -20% | -$41.3K | ﹤0.01% | 1135 |
|
2025
Q1 | $271K | Sell |
3,836
-388
| -9% | -$27.4K | 0.01% | 1061 |
|
2024
Q4 | $278K | Sell |
4,224
-7,227
| -63% | -$475K | 0.01% | 1060 |
|
2024
Q3 | $805K | Buy |
11,451
+180
| +2% | +$12.7K | 0.01% | 789 |
|
2024
Q2 | $928K | Buy |
11,271
+889
| +9% | +$73.2K | 0.02% | 751 |
|
2024
Q1 | $907K | Buy |
10,382
+1,240
| +14% | +$108K | 0.02% | 760 |
|
2023
Q4 | $881K | Sell |
9,142
-991
| -10% | -$95.6K | 0.02% | 750 |
|
2023
Q3 | $897K | Buy |
10,133
+612
| +6% | +$54.2K | 0.02% | 745 |
|
2023
Q2 | $825K | Buy |
9,521
+1,083
| +13% | +$93.9K | 0.02% | 804 |
|
2023
Q1 | $821K | Buy |
8,438
+1,159
| +16% | +$113K | 0.02% | 819 |
|
2022
Q4 | $753K | Buy |
7,279
+6,887
| +1,757% | +$713K | 0.02% | 839 |
|
2022
Q3 | $33K | Sell |
392
-575
| -59% | -$48.4K | ﹤0.01% | 1397 |
|
2022
Q2 | $80K | Sell |
967
-11,675
| -92% | -$966K | ﹤0.01% | 1316 |
|
2022
Q1 | $975K | Sell |
12,642
-743
| -6% | -$57.3K | 0.02% | 812 |
|
2021
Q4 | $1.18M | Sell |
13,385
-262
| -2% | -$23.2K | 0.02% | 786 |
|
2021
Q3 | $1.06M | Sell |
13,647
-5,942
| -30% | -$459K | 0.02% | 796 |
|
2021
Q2 | $1.64M | Sell |
19,589
-126
| -0.6% | -$10.5K | 0.02% | 662 |
|
2021
Q1 | $1.49M | Sell |
19,715
-1,658
| -8% | -$125K | 0.02% | 691 |
|
2020
Q4 | $1.87M | Buy |
21,373
+3,873
| +22% | +$340K | 0.03% | 580 |
|
2020
Q3 | $1.33M | Buy |
17,500
+8,010
| +84% | +$609K | 0.02% | 622 |
|
2020
Q2 | $1.17M | Buy |
9,490
+6,329
| +200% | +$780K | 0.02% | 648 |
|
2020
Q1 | $267K | Buy |
3,161
+57
| +2% | +$4.82K | 0.01% | 1039 |
|
2019
Q4 | $262K | Sell |
3,104
-103
| -3% | -$8.69K | ﹤0.01% | 1140 |
|
2019
Q3 | $216K | Sell |
3,207
-215
| -6% | -$14.5K | ﹤0.01% | 1171 |
|
2019
Q2 | $293K | Sell |
3,422
-134
| -4% | -$11.5K | 0.01% | 1110 |
|
2019
Q1 | $316K | Sell |
3,556
-3,758
| -51% | -$334K | 0.01% | 1221 |
|
2018
Q4 | $623K | Sell |
7,314
-2,621
| -26% | -$223K | 0.01% | 920 |
|
2018
Q3 | $963K | Sell |
9,935
-842
| -8% | -$81.6K | 0.02% | 848 |
|
2018
Q2 | $1.02M | Sell |
10,777
-4,452
| -29% | -$419K | 0.02% | 835 |
|
2018
Q1 | $1.24M | Sell |
15,229
-508
| -3% | -$41.2K | 0.02% | 759 |
|
2017
Q4 | $1.4M | Sell |
15,737
-468
| -3% | -$41.7K | 0.02% | 708 |
|
2017
Q3 | $1.51M | Sell |
16,205
-5,814
| -26% | -$541K | 0.03% | 707 |
|
2017
Q2 | $2M | Sell |
22,019
-410
| -2% | -$37.2K | 0.03% | 627 |
|
2017
Q1 | $1.97M | Sell |
22,429
-6,651
| -23% | -$584K | 0.03% | 638 |
|
2016
Q4 | $2.41M | Sell |
29,080
-218
| -0.7% | -$18.1K | 0.04% | 574 |
|
2016
Q3 | $2.71M | Sell |
29,298
-9,929
| -25% | -$919K | 0.04% | 527 |
|
2016
Q2 | $3.05M | Sell |
39,227
-3,507
| -8% | -$273K | 0.05% | 524 |
|
2016
Q1 | $3.53M | Sell |
42,734
-10,667
| -20% | -$880K | 0.06% | 458 |
|
2015
Q4 | $5.59M | Sell |
53,401
-4,506
| -8% | -$472K | 0.09% | 323 |
|
2015
Q3 | $6.1M | Sell |
57,907
-11,449
| -17% | -$1.21M | 0.1% | 294 |
|
2015
Q2 | $9.49M | Buy |
69,356
+7,617
| +12% | +$1.04M | 0.13% | 217 |
|
2015
Q1 | $7.69M | Buy |
61,739
+5,632
| +10% | +$702K | 0.1% | 255 |
|
2014
Q4 | $5.07M | Sell |
56,107
-3,021
| -5% | -$273K | 0.07% | 341 |
|
2014
Q3 | $4.27M | Buy |
59,128
+899
| +2% | +$64.9K | 0.06% | 381 |
|
2014
Q2 | $3.62M | Buy |
58,229
+6,955
| +14% | +$433K | 0.05% | 423 |
|
2014
Q1 | $3.5M | Buy |
51,274
+6,761
| +15% | +$461K | 0.05% | 399 |
|
2013
Q4 | $3.13M | Buy |
44,513
+9,067
| +26% | +$637K | 0.05% | 414 |
|
2013
Q3 | $2.56M | Buy |
35,446
+9,773
| +38% | +$706K | 0.05% | 439 |
|
2013
Q2 | $1.43M | Buy |
+25,673
| New | +$1.43M | 0.03% | 544 |
|